Carillion (LON:CLLN) Rating Reaffirmed
Carillion (LON:CLLN) just had their share rating of a ‘”Equalwt/In-Line”‘ issued by research analysts at Morgan Stanley, who now has a GBX 370 Estimated Target Price on the 1.34 billion GBP market cap company or a 16.17% upside potential. This key information was announced in an interesting research report on Wednesday, 9 December.
From a total of 9 analysts covering Carillion PLC (LON:CLLN) stock, 5 rate it a ”Buy”, 1 a “Sell”, and 2 a ”Hold”. This means that 63% of the ratings are positive. The highest target price is GBX 422 while the lowest target price is GBX 230. The mean of all analyst targets is GBX 356.22 with a 12.98% above today’s (GBX 308.4) stock price. Carillion PLC was the topic of 21 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Stifel Nicolaus maintained shares on November 30 with “Buy” rating. UBS maintained shares with “Sell” rating and GBX 230 target share price in a report from an October 8. JP Morgan upgraded CLLN stock in a recent report from October 23 to “Overweight” rating. Numis Securities maintained the rating on October 7. Numis Securities has a “Hold” rating and a GBX 355 price target on shares. Finally, Investec downgraded the stock to “Hold” rating in a report issued on an October 9.
Approximately 2.45M shares of stock traded hands or 170.63% up from the average. Carillion plc (LON:CLLN) has declined 10.68% since May 12, 2015 and is downtrending. It has underperformed by 9.88% the S&P500.
Carillion plc is an integrated support services company. The company has a market cap of 1.34 billion GBP. The Firm has a portfolio of Public Private Partnership projects and construction capabilities. It has 12.29 P/E ratio. The Firm operates in four business divisions: Support services, Public Private Partnership projects, Middle East construction services and Construction services.